Illumina Inc. closed $13.90 short of its 52-week high ($144.02), which the company achieved on January 31st.

On Thursday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $132.27 which represents a slight increase of $6.12 or 4.85% from the prior close of $126.15. The stock opened at $128.04 ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

Illumina Inc (ILMN) stock saw a decline, ending the day at $128.82 which represents a decrease of $-1.28 or -0.98% from the prior close of $130.1. The stock opened at $130.49 and touched a low of $128 ...

Throughout Illumina’s more than four-year saga to acquire liquid biopsy company Grail, it insisted the opposition from European regulators has no basis in law. Europe’s highest judicial body ...

Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

In 2023, Illumina, the world's largest gene sequencing company, was hit by the record fine, and was ordered by the Commission to divest Grail. Illumina in December last year had said that it would ...

2 Since then, aside from the Illumina/Grail transaction, the Commission called in a small number of concentrations. The ...

The Dutch competition watchdog is seeking beefed-up powers to probe more small deals that risk crushing competition in ...

As the Distinguished William S. C. Chang Endowed Chair in the UC San Diego Jacobs School of Engineering’s Department of ...

Leerink Partners analyst Puneet Souda reiterated a Buy rating on Quanterix (QTRX – Research Report) today. The company’s shares ...